Global Statistics

All countries
529,736,730
Confirmed
Updated on May 25, 2022 11:36 pm
All countries
486,069,315
Recovered
Updated on May 25, 2022 11:36 pm
All countries
6,306,249
Deaths
Updated on May 25, 2022 11:36 pm
Thursday, May 26, 2022

Global Statistics

All countries
529,736,730
Confirmed
Updated on May 25, 2022 11:36 pm
All countries
486,069,315
Recovered
Updated on May 25, 2022 11:36 pm
All countries
6,306,249
Deaths
Updated on May 25, 2022 11:36 pm
Molderizer and Safe Shield

Biden presses Congress for new covid funding, gets second booster shot

Vaccines don’t always protect infected from ‘long Covid,’ new research shows

FDA: J&J COVID-19 vaccine use limited due to blood clot risk FDA officials said in a statement that they...

Live news: South Korea raises benchmark rate to 1.75% as inflation climbs – Financial Times

Live news: South Korea raises benchmark rate to 1.75% as inflation climbs  Financial Times Source link

Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron

To the Editor: For persons who received a single dose of the Ad26.COV2.S vaccine (Johnson & Johnson–Janssen) against coronavirus disease 2019 (Covid-19),...


The new website — which consolidates efforts launched earlier in the pandemic, such as covidtests.gov and vaccines.gov — also includes information on local virus spread, guidance on travel rules and restrictions, and a new tool to help Americans locate places to receive immediate antiviral treatments if they have covid.

The president spent much of his speech appealing to Congress to move forward on funding the nation’s coronavirus response, warning that “the consequences of congressional inaction” had already meant delayed or canceled orders for vaccines, antiviral medicines and other resources.

“Congress, we need to secure additional supply now,” Biden said, reiterating the White House’s appeal for at least $22 billion in new pandemic funding. “Now. We can’t wait until we find ourselves in the midst of another surge to act. It’ll be too late.”

But Senate Republicans have balked at setting aside additional money, saying they want a full accounting of earlier spending, and House Democrats subsequently rejected a plan to repurpose money already pledged to states.

Senate Majority Leader Charles E. Schumer (D-N.Y.) and Sen. Mitt Romney (R-Utah) have been negotiating a compromise funding package that could be announced this week, administration and congressional aides have said.

Democrats echoed Biden’s urgency.

“If Congress does not act swiftly, we risk losing valuable tools that will have allowed us to get beyond the crisis,” House Majority Whip James E. Clyburn (D-S.C.) said as he chaired a House Oversight panel on the administration’s coronavirus response. “Losing these tools will increase the risk of the crisis returning.”

The president’s speech came as U.S. coronavirus infections and hospitalizations have plunged from the records set in January, driven by the fast-moving omicron variant. But public health experts are bracing for a potential rebound fueled by BA.2, an omicron subvariant that has spurred a surge of cases in Europe and already accounts for more than half of new cases in the United States, according to federal data. Polls have shown that many Americans downplay covid as a priority, with only one-third of voters in a Pew Research survey this month saying the virus is a key issue that will affect their votes in this year’s midterm elections.

Uptake of booster shots has also lagged behind White House goals, even after the Centers for Disease Control and Prevention recommended that Americans get a first booster to bolster their protection, citing evidence that immunity wanes several months after receiving a prior shot or being infected. About one-third of Americans over age 65 and more than half of all adults have yet to receive their first booster shot, according to federal data.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

Vaccines don’t always protect infected from ‘long Covid,’ new research shows

FDA: J&J COVID-19 vaccine use limited due to blood clot risk FDA officials said in a statement that they...

Live news: South Korea raises benchmark rate to 1.75% as inflation climbs – Financial Times

Live news: South Korea raises benchmark rate to 1.75% as inflation climbs  Financial Times Source link

Related Articles

Vaccines don’t always protect infected from ‘long Covid,’ new research shows

FDA: J&J COVID-19 vaccine use limited due to blood clot risk FDA officials said in a statement that they...

Live news: South Korea raises benchmark rate to 1.75% as inflation climbs – Financial Times

Live news: South Korea raises benchmark rate to 1.75% as inflation climbs  Financial Times Source link